Last reviewed · How we verify
Placebo of Lyrica
Placebo of Lyrica is a Small molecule drug developed by KunWha Pharmaceutical Co., Ltd.. It is currently in Phase 3 development.
This is a placebo control formulation used in clinical trials to compare against the active drug Lyrica (pregabalin).
At a glance
| Generic name | Placebo of Lyrica |
|---|---|
| Sponsor | KunWha Pharmaceutical Co., Ltd. |
| Modality | Small molecule |
| Phase | Phase 3 |
Mechanism of action
As a placebo, this formulation contains no active pharmaceutical ingredient and serves as a control arm in phase 3 clinical trials. It allows researchers to isolate the true therapeutic effect of pregabalin by comparing outcomes in patients receiving placebo versus the active drug. Placebos are essential for blinded, randomized controlled trials to establish efficacy and safety profiles.
Approved indications
Common side effects
Key clinical trials
- Effects of 2-Aticyto Complex and D-Ribose on Pain and Clinical Course in Patients With Fibromyalgia (NA)
- Evaluation of Efficacy and Safety of VX-993 for Pain Associated With Diabetic Peripheral Neuropathy (PHASE2)
- Effect of Pregabalin on the Postoperative Analgesia in RFA of Focal Lesions in the Liver (PHASE4)
- A Study of HRS-2129 in Patients With Diabetic Peripheral Neuropathic Pain (PHASE1)
- Adding Amantadine or Duloxetine to Pregabalin on Occurrence of Post Mastectomy Pain Syndrome (NA)
- Pregabalin Plus Lofexidine for the Outpatient Treatment of Opioid Withdrawal (PHASE2)
- The Effects of Preemptive Multimodal Analgesic on Endodontic Pain Following Root Canal Therapy. (EARLY_PHASE1)
- Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Placebo of Lyrica CI brief — competitive landscape report
- Placebo of Lyrica updates RSS · CI watch RSS
- KunWha Pharmaceutical Co., Ltd. portfolio CI
Frequently asked questions about Placebo of Lyrica
What is Placebo of Lyrica?
How does Placebo of Lyrica work?
Who makes Placebo of Lyrica?
What development phase is Placebo of Lyrica in?
Related
- Manufacturer: KunWha Pharmaceutical Co., Ltd. — full pipeline
- Compare: Placebo of Lyrica vs similar drugs
- Pricing: Placebo of Lyrica cost, discount & access